ArticleThe patient2026

Experiences of People with Type 2 Diabetes and Healthcare Professionals with Once-Weekly Insulin Efsitora Alfa in QWINT Phase 3 Trials: Qualitative In-Trial Interviews.

William H Polonsky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.